LBO — SUMMIT MEDICAL CENTER
IRR: 21.3% | MOIC: 2.62x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
21.3%
IRR
2.62x
MOIC
$302.7M
Entry EV
$544.6M
Exit EV
$155.7M
Equity Invested
Sources & Uses
S&UTotal · $302.7M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $117.5M | 38.8% | |
| Sub Debt | $29.4M | 9.7% | |
| Equity | $155.7M | 51.5% | |
| Enterprise Value | $293.9M | 97.1% | |
| Transaction Fees | $8.8M | 2.9% | |
| Total Uses | $302.7M | 100.0% |
Interpretation
INTAt 2.62x MOIC and 21.3% IRR over 5 years, this deal exceeds the typical 20% hurdle — strong candidate.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $51.9M |
| Exit Ev | $544.6M |
| Net Debt At Exit | $136.3M |
| Equity At Exit | $408.3M |
| Equity Invested | $155.7M |
| Total Value Created | $252.6M |
| Value From Growth | $236.0M |
| Value From Multiple | $14.7M |
| Value From Deleveraging | $10.7M |